Interferon Alpha-2b (IFNα2b)

Interferon Alpha-2b (IFNα2b) is a cytokine with antiviral and immunomodulatory properties, commonly used in the treatment of various viral infections and cancers. Glycosylation of  IFNα2b enhances the stability and biological activity of this protein, expanding its therapeutic potential. IFNα2b glycopeptides are utilized in treating chronic viral infections, such as hepatitis B and C, by boosting the immune response and inhibiting viral replication. Their enhanced stability also improves their efficacy in cancer therapy, particularly for certain types of leukemia and melanoma, where they help to modulate the immune system to target and destroy cancer cells. Additionally, research into IFNα2b glycopeptides explores their potential in managing autoimmune disorders and other inflammatory conditions, with the goal of developing more effective and targeted treatments.